Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent

BSE2698.700.45 (+0.02 %)

PREV CLOSE ( ) 2698.25

OPEN PRICE ( ) 2708.20

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 133

TODAY'S LOW / HIGH ( )2698.70 2711.95

52 WK LOW / HIGH ( )1636.25 2782

NSE2707.008.3 (+0.31 %)

PREV CLOSE( ) 2698.70

OPEN PRICE ( ) 2719.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 2707.00 (3)

VOLUME 10293

TODAY'S LOW / HIGH( ) 2691.95 2721.60

52 WK LOW / HIGH ( )1636.85 2782.85

Select year

(Rs.in Million)

Particulars

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Mar 2019

Profit Before Tax

18471.60

12259.10

15262.60

11865.70

5616.60

Adjustment

9372.40

13499.50

9928.40

8762.10

14181.90

Changes In working Capital

-182.00

-3518.50

-3382.50

-3858.30

993.90

Cash Flow after changes in Working Capital

27662.00

22240.10

21808.50

16769.50

20792.40

Cash Flow from Operating Activities

23681.30

18029.90

20053.50

13929.10

17980.80

Cash Flow from Investing Activities

-24153.10

-1966.30

-4494.20

1986.10

-2412.80

Cash Flow from Financing Activities

773.60

-17810.50

-16507.90

-15490.40

-13144.50

Net Cash Inflow / Outflow

301.80

-1746.90

-948.60

424.80

2423.50

Opening Cash & Cash Equivalents

3984.00

5725.60

6618.20

5887.60

7020.40

Cash & Cash Equivalent on Amalgamation / Take over / Merger

588.30

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

211.20

5.30

56.00

305.80

-43.30

Closing Cash & Cash Equivalent

5085.30

3984.00

5725.60

6618.20

9400.60